# Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients

> **NCT02581033** · NA · UNKNOWN · sponsor: **St Vincent's Hospital Melbourne** · enrollment: 200 (estimated)

## Conditions studied

- Chronic Hepatitis B.

## Interventions

- **DRUG:** Nucleoside Analogue therapy

## Key facts

- **NCT ID:** NCT02581033
- **Lead sponsor:** St Vincent's Hospital Melbourne
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2018-05
- **Final completion:** 2018-05
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2016-10-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02581033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02581033, "Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT02581033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*